Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer.
Zoe E BetteridgeLynsey PriestRobert G CooperNeil J McHughFiona BlackhallJanine A LambPublished in: Arthritis research & therapy (2018)
Myositis and scleroderma specific autoantibodies, including anti-TIF1, anti-NXP2 and anti-RNA polymerase III, are rare in patients with lung cancer without an autoimmune disease. We report here the first case of anti-EJ autoantibodies being detected in a patient with lung cancer without clinical or radiographic evidence of the anti-synthetase syndrome.